Exagen (XGN) News Today $6.03 +0.26 (+4.51%) Closing price 04:00 PM EasternExtended Trading$5.66 -0.37 (-6.12%) As of 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Stonepine Capital Management LLC Reduces Stock Holdings in Exagen Inc. (NASDAQ:XGN)Stonepine Capital Management LLC trimmed its holdings in shares of Exagen Inc. (NASDAQ:XGN - Free Report) by 53.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 251,049 shares of the company's stock aMay 20 at 7:02 AM | marketbeat.comResearch Analysts Issue Forecasts for Exagen FY2025 EarningsExagen Inc. (NASDAQ:XGN - Free Report) - Analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Exagen in a research report issued on Thursday, May 15th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings of ($0.61) per share for the year, downMay 20 at 2:25 AM | marketbeat.comFY2025 EPS Estimates for Exagen Reduced by Cantor FitzgeraldMay 20 at 2:21 AM | americanbankingnews.comCantor Fitzgerald Cuts Exagen (NASDAQ:XGN) Price Target to $7.00May 18, 2025 | americanbankingnews.comExagen (NASDAQ:XGN) Price Target Raised to $8.00May 16, 2025 | americanbankingnews.comCanaccord Genuity Group Issues Positive Forecast for Exagen (NASDAQ:XGN) Stock PriceCanaccord Genuity Group lifted their target price on Exagen from $7.00 to $8.00 and gave the stock a "buy" rating in a research report on Tuesday.May 15, 2025 | marketbeat.comDriehaus Capital Management LLC Takes Position in Exagen Inc. (NASDAQ:XGN)Driehaus Capital Management LLC purchased a new position in shares of Exagen Inc. (NASDAQ:XGN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 418,505 shares of the company's stockMay 12, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call TranscriptMay 11, 2025 | insidermonkey.comWilliam Blair Has Pessimistic Outlook of Exagen Q2 EarningsExagen Inc. (NASDAQ:XGN - Free Report) - William Blair reduced their Q2 2025 earnings estimates for shares of Exagen in a research report issued to clients and investors on Monday, May 5th. William Blair analyst A. Brackmann now forecasts that the company will earn ($0.18) per share for the quartMay 10, 2025 | marketbeat.comExagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional SharesMay 9, 2025 | finance.yahoo.comExagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional SharesMay 9, 2025 | globenewswire.comWilliam Blair Forecasts Exagen's Q1 Earnings (NASDAQ:XGN)Exagen Inc. (NASDAQ:XGN - Free Report) - Investment analysts at William Blair issued their Q1 2026 earnings per share estimates for shares of Exagen in a report issued on Monday, May 5th. William Blair analyst A. Brackmann forecasts that the company will post earnings per share of ($0.08) for theMay 9, 2025 | marketbeat.comExagen Inc. Prices Public Offering of Common StockMay 8, 2025 | globenewswire.comKeyBanc maintains Exagen stock at Sector WeightMay 7, 2025 | investing.comKeyBanc maintains Exagen stock at Sector WeightMay 7, 2025 | investing.comExagen Inc. Announces Proposed Public Offering of Common StockMay 7, 2025 | globenewswire.comExagen (NASDAQ:XGN) Issues Quarterly Earnings ResultsExagen (NASDAQ:XGN - Get Free Report) issued its earnings results on Monday. The company reported ($0.20) EPS for the quarter, meeting the consensus estimate of ($0.20). Exagen had a negative net margin of 30.36% and a negative return on equity of 92.58%. During the same period in the prior year, the firm posted ($0.19) EPS.May 7, 2025 | marketbeat.comExagen (XGN) Expected to Announce Earnings on MondayExagen (NASDAQ:XGN) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-exagen-inc-stock/)May 7, 2025 | marketbeat.comEarnings call transcript: Exagen Inc. Q1 2025 revenue beats forecasts, stock dipsMay 6, 2025 | uk.investing.comExagen Inc. Reports Record Revenue Amid Strategic GrowthMay 6, 2025 | tipranks.comExagen Inc. Earnings Call Highlights Record GrowthMay 5, 2025 | tipranks.comExagen Inc. (XGN) Q1 2025 Earnings Call TranscriptMay 5, 2025 | seekingalpha.comExagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing VolumeMay 5, 2025 | globenewswire.comExagen Inc (XGN) Q1 2025 Earnings Report Preview: What To ExpectMay 3, 2025 | finance.yahoo.comExagen Inc. Announces Senior Secured Credit Facility with Perceptive AdvisorsApril 28, 2025 | globenewswire.comExagen: Buy An Undervalued Diagnostics Developer That Is On The Path To ProfitabilityApril 26, 2025 | seekingalpha.comInstitutional investors control 30% of Exagen Inc. (NASDAQ:XGN) and were rewarded last week after stock increased 30%April 25, 2025 | finance.yahoo.comExagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025April 21, 2025 | globenewswire.comExagen Inc. (NASDAQ:XGN) Shares Sold by Wasatch Advisors LPWasatch Advisors LP decreased its position in shares of Exagen Inc. (NASDAQ:XGN - Free Report) by 91.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,975 shares of the company's stockApril 20, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Short Interest UpdateExagen Inc. (NASDAQ:XGN - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 46,200 shares, an increase of 162.5% from the March 15th total of 17,600 shares. Based on an average daily volume of 135,600 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.5% of the shares of the stock are short sold.April 16, 2025 | marketbeat.comShort Interest in Exagen Inc. (NASDAQ:XGN) Drops By 23.5%Exagen Inc. (NASDAQ:XGN - Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 17,600 shares, a decline of 23.5% from the February 28th total of 23,000 shares. Based on an average trading volume of 146,200 shares, the short-interest ratio is currently 0.1 days. Approximately 0.2% of the shares of the company are sold short.March 31, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Sees Significant Decline in Short InterestExagen Inc. (NASDAQ:XGN - Get Free Report) was the recipient of a large drop in short interest in February. As of February 28th, there was short interest totalling 23,000 shares, a drop of 29.2% from the February 13th total of 32,500 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average trading volume of 166,100 shares, the days-to-cover ratio is currently 0.1 days.March 16, 2025 | marketbeat.comCantor Fitzgerald Reduces Earnings Estimates for ExagenExagen Inc. (NASDAQ:XGN - Free Report) - Cantor Fitzgerald decreased their FY2025 earnings estimates for Exagen in a research note issued to investors on Wednesday, March 12th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will earn ($0.59) per share for the year, down fromMarch 15, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?March 14, 2025 | finance.yahoo.comWilliam Blair Predicts Exagen's FY2026 Earnings (NASDAQ:XGN)Exagen Inc. (NASDAQ:XGN - Free Report) - William Blair issued their FY2026 earnings estimates for Exagen in a note issued to investors on Wednesday, March 12th. William Blair analyst A. Brackmann anticipates that the company will post earnings of ($0.23) per share for the year. William Blair hasMarch 14, 2025 | marketbeat.comWilliam Blair Reiterates Outperform Rating for Exagen (NASDAQ:XGN)William Blair reaffirmed an "outperform" rating on shares of Exagen in a report on Wednesday.March 13, 2025 | marketbeat.comExagen Full Year 2024 Earnings: EPS Beats ExpectationsMarch 12, 2025 | uk.finance.yahoo.comExagen Inc. (NASDAQ:XGN) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | msn.comExagen (XGN) Gets a Buy from Canaccord GenuityMarch 12, 2025 | markets.businessinsider.comExagen Inc. Reports Record Revenue and Positive OutlookMarch 12, 2025 | tipranks.comExagen (NASDAQ:XGN) Releases Quarterly Earnings Results, Beats Estimates By $0.07 EPSExagen (NASDAQ:XGN - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.07. Exagen had a negative return on equity of 92.58% and a negative net margin of 30.36%.March 12, 2025 | marketbeat.comCantor Fitzgerald Forecasts Increased Earnings for ExagenExagen Inc. (NASDAQ:XGN - Free Report) - Stock analysts at Cantor Fitzgerald boosted their FY2024 EPS estimates for Exagen in a research note issued on Monday, March 10th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings per share of ($0.84) for the year, upMarch 12, 2025 | marketbeat.comExagen reports Q4 EPS (20c), consensus (24c)March 12, 2025 | markets.businessinsider.comExagen Inc. Reports Record 2024 Financial ResultsMarch 12, 2025 | tipranks.comExagen Inc. (XGN) Q4 2024 Earnings Call TranscriptMarch 11, 2025 | seekingalpha.comExagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business HighlightsMarch 11, 2025 | globenewswire.comExagen (XGN) to Release Quarterly Earnings on TuesdayExagen (NASDAQ:XGN) will be releasing earnings before the market opens on Tuesday, March 11, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=292486)March 4, 2025 | marketbeat.comInvestors in Exagen (NASDAQ:XGN) have unfortunately lost 84% over the last five yearsMarch 2, 2025 | finance.yahoo.comExagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025February 25, 2025 | globenewswire.comExagen Inc. (NASDAQ:XGN) Short Interest Up 260.8% in JanuaryExagen Inc. (NASDAQ:XGN - Get Free Report) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 26,700 shares, a growth of 260.8% from the January 15th total of 7,400 shares. Based on an average daily volume of 170,600 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.3% of the company's stock are sold short.February 12, 2025 | marketbeat.com Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address XGN Media Mentions By Week XGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XGN News Sentiment▼-0.080.69▲Average Medical News Sentiment XGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XGN Articles This Week▼82▲XGN Articles Average Week Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EHAB News AUNA News TALK News LFMD News CSTL News PSNL News CELC News FTRE News SBC News VMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XGN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XGN Stock Free XGN Stock Alerts